References
1. Li PH, Yeung HHF, Lau CS, Au EYL. Prevalence, Incidence, and Sensitization Profile of β-lactam Antibiotic Allergy in Hong Kong.JAMA Netw Open. 2020;3(5):e204199.
2. Zhou L, Dhopeshwarkar N, Blumenthal KG, et al. Drug allergies documented in electronic health records of a large healthcare system.Allergy. 2016;71(9):1305-1313.
3. Blumenthal KG, Peter JG, Trubiano JA, Phillips EJ. Antibiotic allergy. Lancet. 2019;393(10167):183-198.
4. Mayer-Schönberger V, Ingelsson E. Big Data and medicine: a big deal?J Intern Med. 2018;283(5):418-429.
5. Thong BY, Lucas M, Kang HR, et al. Drug hypersensitivity reactions in Asia: regional issues and challenges. Asia Pac Allergy.2020;10(1):e8.
6. Mak HWF, Yeung MHY, Wong JCY, Chiang V, Li PH. Differences in beta-lactam and penicillin allergy: Beyond the West and focusing on Asia-Pacific. Front Allergy. 2022;3:1059321.
7. Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and Management of Penicillin Allergy: A Review. JAMA. 2019;321(2):188-199.
8. Li PH, Siew LQC, Thomas I, et al. Beta-lactam allergy in Chinese patients and factors predicting genuine allergy. World Allergy Organ J. 2019;12(8):100048.
9. Siew LQC, Li PH, Watts TJ, et al. Identifying Low-Risk Beta-Lactam Allergy Patients in a UK Tertiary Centre. J Allergy Clin Immunol Pract. 2019;7(7):2173-2181.e2171.
10. Kan AKC, Hui HKS, Li TS, et al. Comparative Effectiveness, Safety, and Real-World Outcomes of a Nurse-Led, Protocol-Driven Penicillin Allergy Evaluation From the Hong Kong Drug Allergy Delabelling Initiative (HK-DADI). J Allergy Clin Immunol Pract.2023;11(2):474-480 e472.
11. Venturini Díaz M, Vidal Oribe I, D’Elia Torrence D, Hernández Alfonso P, Alarcón Gallardo E. New Challenges in Drug Allergy: the Resurgence of Excipients. Curr Treat Options Allergy.2022;9(3):273-291.
12. Li PH, Wagner A, Thomas I, Watts TJ, Rutkowski R, Rutkowski K. Steroid Allergy: Clinical Features and the Importance of Excipient Testing in a Diagnostic Algorithm. J Allergy Clin Immunol Pract.2018;6(5):1655-1661.
13. Li PH, Yeung HHF, Lau CS, Au EYL. Excipient allergy and importance of complete allergy histories. J Allergy Clin Immunol Pract.2020;8(6):2122-2123.
14. Caballero ML, Krantz MS, Quirce S, Phillips EJ, Stone CA, Jr. Hidden Dangers: Recognizing Excipients as Potential Causes of Drug and Vaccine Hypersensitivity Reactions. J Allergy Clin Immunol Pract.2021;9(8):2968-2982.
15. Caballero ML, Quirce S. Immediate Hypersensitivity Reactions Caused by Drug Excipients: A Literature Review. J Investig Allergol Clin Immunol. 2020;30(2):86-100.
16. Chiang V, Leung ASY, Au EYL, et al. Consensus Statements on the Approach to COVID-19 Vaccine Allergy Safety in Hong Kong. Front Allergy. 2021;2.
17. Chiang V, Leung ASY, Au EYL, et al. Updated consensus statements on COVID-19 Vaccine Allergy Safety in Hong Kong. Asia Pac Allergy.2022;12(1):e8.
18. Kan AKC, Wong TTH, Chiang V, Lau CS, Li PH. Chronic Spontaneous Urticaria in Hong Kong: Clinical Characteristics, Real-World Practice and Implications for COVID-19 Vaccination. Allergy Asthma Immunol Res. 2023;15(1):32-42.
19. Hospital Authority. Hospital Authority Annual Report. [Internet]. 2018; about 215 p. Available at: https://www.ha.org.hk/haho/ho/cc/HA_Annual_Report_2020-21_en.pdf. Accessed Jun 13, 2022.
20. British Medical Association, Royal Pharmaceutical Society. BNF 83. London, United Kindgom: BMJ Group and the Royal Pharmaceutical Society of Great Britain; 2022.
21. Xin H, Wu P, Wong JY, et al. Hospitalizations and mortality during the first year of the COVID-19 pandemic in Hong Kong, China: An observational study. Lancet Reg Health West Pac. 2023;30:100645.
22. Li PH, Chung HY, Lau CS. Epidemiology and outcomes of geriatric and non-geriatric patients with drug allergy labels in Hong Kong. Hong Kong Med J. 2021;27(3):192-197.
23. Yuson C, Shakib S, Smith W. Prevalence of drug allergy in South Australia. Intern Med J. 2022;52(11):1957-1961.
24. Kvedariene V, Sitkauskiene B, Tamasauskiene L, et al. Prevalence of self-reported drug hypersensitivity reactions among Lithuanian children and adults. Allergol Immunopathol (Madr). 2019;47(1):32-37.
25. Thong BY, Tan TC. Epidemiology and risk factors for drug allergy.Br J Clin Pharmacol. 2011;71(5):684-700.
26. Macy E, Poon KYT. Self-reported antibiotic allergy incidence and prevalence: age and sex effects. Am J Med. 2009;122(8):778 e771-777.
27. Stone CA, Jr., Trubiano J, Coleman DT, Rukasin CRF, Phillips EJ. The challenge of de-labeling penicillin allergy. Allergy.2020;75(2):273-288.
28. Lee TH, Leung TF, Wong G, et al. The unmet provision of allergy services in Hong Kong impairs capability for allergy prevention-implications for the Asia Pacific region. Asian Pac J Allergy Immunol. 2019;37(1):1-8.
29. Cheng VC, Wong SC, Ho PL, Yuen KY. Strategic measures for the control of surging antimicrobial resistance in Hong Kong and mainland of China. Emerg Microbes Infect. 2015;4(2):e8.
30. Li PH, Cheng VC, Yip T, Yap DY, Lui SL, Lo WK. Epidemiology and Clinical Characteristics of Acinetobacter Peritoneal Dialysis-Related Peritonitis in Hong Kong-With a Perspective on Multi-Drug and Carbapenem Resistance. Perit Dial Int. 2017;37(2):177-182.
31. Chan SCW, Yeung WWY, Wong JCY, et al. Prevalence and Impact of Reported Drug Allergies among Rheumatology Patients. Diagnostics (Basel). 2020;10(11).
32. West RM, Smith CJ, Pavitt SH, et al. ‘Warning: allergic to penicillin’: association between penicillin allergy status in 2.3 million NHS general practice electronic health records, antibiotic prescribing and health outcomes. J Antimicrob Chemother.2019;74(7):2075-2082.
33. Mattingly TJ, 2nd, Fulton A, Lumish RA, et al. The Cost of Self-Reported Penicillin Allergy: A Systematic Review. J Allergy Clin Immunol Pract. 2018;6(5):1649-1654.e1644.
34. Chiang V, Saha C, Yim J, et al. The Role of the Allergist in Coronavirus Disease 2019 Vaccine Allergy Safety: A Pilot Study on a ”Hub-and-Spoke” Model for Population-Wide Allergy Service. Ann Allergy Asthma Immunol. 2022;129(3):308-312.e301.
35. Chiang V, To KKW, Hung IFN, et al. COVID-19 Vaccine Allergy Safety Track (VAS-Track) pathway: real-world outcomes on vaccination rates and antibody protection. Asian Pac J Allergy Immunol. 2023.